Franklin Genomic Advancem... (HELX)
CBOE: HELX
· Real-Time Price · USD
31.86
0.91 (2.94%)
At close: Oct 01, 2025, 3:36 PM
2.94% (1D)
| Bid | 23.89 |
| Market Cap | 13.18M |
| AUM | 16.78M |
| NAV | 30.5 |
| EPS (ttm) | 1.01 |
| PE Ratio (ttm) | 31.50 |
| Shares Out | 413.7K |
| Inception Date | Feb 24, 2020 |
| Ask | 35.82 |
| Volume | 40,028 |
| Open | 31.65 |
| Previous Close | 30.95 |
| Day's Range | 31.65 - 31.87 |
| 52-Week Range | 23.74 - 32.43 |
| Holdings | 63 |
| Expense Ratio | 0.50% |
About HELX
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
Asset Class Equity
Ticker Symbol HELX
Inception Date Feb 24, 2020
Provider Franklin Templeton
Website Fund Home Page
Exchange CBOE
Top Sectors
| Sector | Weight % |
|---|---|
| Healthcare | 94.34% |
| Basic Materials | 3.17% |
| Technology | 2.49% |
Top 10 Holdings 41.88% of assets
| Name | Symbol | Weight |
|---|---|---|
| Natera, Inc. | NTRA | 5.93% |
| Alnylam Pharmaceutic... | ALNY | 4.89% |
| Guardant Health, Inc... | GH | 4.81% |
| Medpace Holdings, In... | MEDP | 4.69% |
| Insmed Incorporated | INSM | 4.14% |
| Krystal Biotech, Inc... | KRYS | 3.78% |
| United Therapeutics ... | UTHR | 3.71% |
| Tempus Ai, Inc. | TEM | 3.39% |
| Ligand Pharmaceutica... | LGND | 3.29% |
| Adaptive Biotechnolo... | ADPT | 3.25% |
Dividends Dividend Yield 0.24%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 30, 2021 | $0.0039 | Jan 7, 2022 |
| Dec 13, 2021 | $0.1142 | Dec 21, 2021 |
| Dec 14, 2020 | $0.0518 | Dec 23, 2020 |
